ID

41075

Descripción

Inotuzumab Ozogamycin in Elderly Acute Lymphoblastic Leukemia (ALL); ODM derived from: https://clinicaltrials.gov/show/NCT01371630

Link

https://clinicaltrials.gov/show/NCT01371630

Palabras clave

Versiones (1)
  1. 19/6/20 19/6/20 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

19 de junio de 2020

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Leukemia NCT01371630

Inglés

Eligibility Leukemia NCT01371630

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT01371630
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients age 60 years or older with previously untreated all of pre-b, philadelphia chromosome (ph-) negative all. minimal prior therapy (less than 1 week of steroids, vincristine, and/or 1 dose of anthracycline or alkylating agents) are allowed.
Descripción

Age | Pre B-cell acute lymphoblastic leukemia Untreated | Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | Prior Therapy Minimal | Steroids | Vincristine | Anthracyclines | Alkylating Agents

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0349636
UMLS CUI [2,2]
C0332155
UMLS CUI [3]
C4289946
UMLS CUI [4,1]
C1514463
UMLS CUI [4,2]
C0547040
UMLS CUI [5]
C0038317
UMLS CUI [6]
C0042679
UMLS CUI [7]
C0282564
UMLS CUI [8]
C0002073
2. zubrod performance status 0-3.
Descripción

Zubrod Performance Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3714786
3. adequate liver function (bilirubin </= 1.5 mg/dl and sgpt or sgot </= 3 x upper limit of normal [uln], unless considered due to tumor), and renal function (creatinine </= 2 mg/dl). even if organ function abnormalities are considered due to tumor, the upper limit for bilirubin is </= 2.0 mg/dl and creatinine </= 3 mg/dl.
Descripción

Liver function | Serum total bilirubin measurement | Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Exception Due to Neoplasm | Renal function | Creatinine measurement, serum | Organ function Abnormality Due to Neoplasm

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201836
UMLS CUI [4]
C0201899
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0678226
UMLS CUI [5,3]
C0027651
UMLS CUI [6]
C0232804
UMLS CUI [7]
C0201976
UMLS CUI [8,1]
C0678852
UMLS CUI [8,2]
C1704258
UMLS CUI [8,3]
C0678226
UMLS CUI [8,4]
C0027651
4. provision of written informed consent.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
5. patients in first remission are eligible.
Descripción

Remission First

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0544452
UMLS CUI [1,2]
C0205435
6. patients with refractory-relapsed all of any age are eligible, provided they are not eligible for regimens of higher priority. currently study 2012-0151 (inotuzumab vs. intensive chemotherapy in all salvage 1 and 2) is an fda pivotal trial and is a higher priority (september 10, 2012).
Descripción

Refractory acute lymphoid leukemia | Acute lymphocytic leukemia recurrent | Age | Ineligibility Clinical Trial High priority

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4302097
UMLS CUI [2]
C1504403
UMLS CUI [3]
C0001779
UMLS CUI [4,1]
C1512714
UMLS CUI [4,2]
C0008976
UMLS CUI [4,3]
C1273516
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. ph-positive all, burkitt's leukemia or lymphoma, t-cell all or lymphoblastic lymphoma.
Descripción

Philadelphia positive acute lymphocytic leukaemia | Burkitt Lymphoma | T-ALL | Lymphoblastic Lymphoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4524071
UMLS CUI [2]
C0006413
UMLS CUI [3]
C1961099
UMLS CUI [4]
C0855146
2. patient with active heart disease (nyha class >/= 3 as assessed by history and physical examination).
Descripción

Heart Disease New York Heart Association Classification

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C1275491
3. patients with a cardiac ejection fraction (as measured by either muga or echocardiogram) < 40% are excluded.
Descripción

Cardiac ejection fraction MUGA scan | Cardiac ejection fraction Echocardiography

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0232174
UMLS CUI [1,2]
C0521317
UMLS CUI [2,1]
C0232174
UMLS CUI [2,2]
C0013516
4. patients with active hepatitis are excluded.
Descripción

Hepatitis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019158
5. pregnant or breast-feeding women are excluded.
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Volver a la parte superior de la página

Similar models

Eligibility Leukemia NCT01371630

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT01371630
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age | Pre B-cell acute lymphoblastic leukemia Untreated | Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | Prior Therapy Minimal | Steroids | Vincristine | Anthracyclines | Alkylating Agents
Item
1. patients age 60 years or older with previously untreated all of pre-b, philadelphia chromosome (ph-) negative all. minimal prior therapy (less than 1 week of steroids, vincristine, and/or 1 dose of anthracycline or alkylating agents) are allowed.
boolean
C0001779 (UMLS CUI [1])
C0349636 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
C4289946 (UMLS CUI [3])
C1514463 (UMLS CUI [4,1])
C0547040 (UMLS CUI [4,2])
C0038317 (UMLS CUI [5])
C0042679 (UMLS CUI [6])
C0282564 (UMLS CUI [7])
C0002073 (UMLS CUI [8])
Zubrod Performance Status
Item
2. zubrod performance status 0-3.
boolean
C3714786 (UMLS CUI [1])
Liver function | Serum total bilirubin measurement | Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Exception Due to Neoplasm | Renal function | Creatinine measurement, serum | Organ function Abnormality Due to Neoplasm
Item
3. adequate liver function (bilirubin </= 1.5 mg/dl and sgpt or sgot </= 3 x upper limit of normal [uln], unless considered due to tumor), and renal function (creatinine </= 2 mg/dl). even if organ function abnormalities are considered due to tumor, the upper limit for bilirubin is </= 2.0 mg/dl and creatinine </= 3 mg/dl.
boolean
C0232741 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201899 (UMLS CUI [4])
C1705847 (UMLS CUI [5,1])
C0678226 (UMLS CUI [5,2])
C0027651 (UMLS CUI [5,3])
C0232804 (UMLS CUI [6])
C0201976 (UMLS CUI [7])
C0678852 (UMLS CUI [8,1])
C1704258 (UMLS CUI [8,2])
C0678226 (UMLS CUI [8,3])
C0027651 (UMLS CUI [8,4])
Informed Consent
Item
4. provision of written informed consent.
boolean
C0021430 (UMLS CUI [1])
Remission First
Item
5. patients in first remission are eligible.
boolean
C0544452 (UMLS CUI [1,1])
C0205435 (UMLS CUI [1,2])
Refractory acute lymphoid leukemia | Acute lymphocytic leukemia recurrent | Age | Ineligibility Clinical Trial High priority
Item
6. patients with refractory-relapsed all of any age are eligible, provided they are not eligible for regimens of higher priority. currently study 2012-0151 (inotuzumab vs. intensive chemotherapy in all salvage 1 and 2) is an fda pivotal trial and is a higher priority (september 10, 2012).
boolean
C4302097 (UMLS CUI [1])
C1504403 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
C1512714 (UMLS CUI [4,1])
C0008976 (UMLS CUI [4,2])
C1273516 (UMLS CUI [4,3])
Item Group
C0680251 (UMLS CUI)
Philadelphia positive acute lymphocytic leukaemia | Burkitt Lymphoma | T-ALL | Lymphoblastic Lymphoma
Item
1. ph-positive all, burkitt's leukemia or lymphoma, t-cell all or lymphoblastic lymphoma.
boolean
C4524071 (UMLS CUI [1])
C0006413 (UMLS CUI [2])
C1961099 (UMLS CUI [3])
C0855146 (UMLS CUI [4])
Heart Disease New York Heart Association Classification
Item
2. patient with active heart disease (nyha class >/= 3 as assessed by history and physical examination).
boolean
C0018799 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Cardiac ejection fraction MUGA scan | Cardiac ejection fraction Echocardiography
Item
3. patients with a cardiac ejection fraction (as measured by either muga or echocardiogram) < 40% are excluded.
boolean
C0232174 (UMLS CUI [1,1])
C0521317 (UMLS CUI [1,2])
C0232174 (UMLS CUI [2,1])
C0013516 (UMLS CUI [2,2])
Hepatitis
Item
4. patients with active hepatitis are excluded.
boolean
C0019158 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
5. pregnant or breast-feeding women are excluded.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial